澳门大阳城122.ccapp官方下载

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Colquhounia Root Tablet Protects Rat Pulmonary Microvascular Endothelial Cells against TNF--Induced Injury by Upregulating the Expression of Tight Junction Proteins Claudin-5 and ZO-1.

Evid Based Complement Alternat Med. 2018; 
Zhou Wenjie,Shi Guocui,Bai Jijia,Ma Shenmao,Liu Qinfu,Ma Xi
Products/Services Used Details Operation
Gene Synthesis Te primers were designed and synthesized by Genscript Inc. (Nanjing, China): Claudin-5 forward 5’-CAGCGTTGGAAATTCTGGGTC-3’, reverse 5’-ACACTTTGCATTGCATGTGCC-3’; ZO-1 forward 5’-TGGTGCTCCTAAACAATC-3’, reverse 5’-TGCTATTACACGGTCCTC-3’; and �- actin forward 5’-CCCATCTATGAGGGTTACGC-3’, reverse 5’-TTTAATGTCACGCACGATTTC-3’. Get A Quote

摘要

There are currently limited effective pharmacotherapy agents for acute lung injury (ALI). Inflammatory response in the lungs is the main pathophysiological process of ALI. Our preliminary data have shown that colquhounia root tablet (CRT), a natural herbal medicine, alleviates the pulmonary inflammatory responses and edema in a rat model with oleic acid-induced ALI. However, the potential molecular action mechanisms underlining its protective effects against ALI are poorly understood. This study aimed to investigate the effects and mechanism of CRT in rat pulmonary microvascular endothelial cells (PMEC) with TNF--induced injury.

关键词